HomeNewsIndiaHome isolation allowed for mildly symptomatic patients in Mumbai, period reduced to 7 days

Home isolation allowed for mildly symptomatic patients in Mumbai, period reduced to 7 days

Amid an exponential rise in cases in Mumbai, the BMC also reduced the minimum period of home isolation to seven days from the earlier 14 days.

January 07, 2022 / 09:09 IST
Story continues below Advertisement
Authorities said they were keeping an eye on a new strain of the Delta variant of the virus which is also spreading in England, but believed existing vaccines could cope with it. (Image: Reuters)
Authorities said they were keeping an eye on a new strain of the Delta variant of the virus which is also spreading in England, but believed existing vaccines could cope with it. (Image: Reuters)

The Brihanmumbai Municipal Corporation (BMC) on Thursday said the COVID-19 patients with mild symptoms can stay in home isolation instead of institutional quarantine or hospital.

Amid an exponential rise in cases in Mumbai, the BMC also reduced the minimum period of home isolation to seven days from the earlier 14 days.

Story continues below Advertisement

According to fresh guidelines issued by the BMC on Thursday night, home isolation will continue for at least seven days from testing positive. It can end after the patient does not report fever for three days in a row.

"There is no need for re-testing after the home isolation period is over," said the guidelines, mainly based on the union government’s guidelines about home quarantine issued on January 5, 2022.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show